Hosted on MSN2h
FDA Grants Fast Track Designation to PleoPharma’s PP-01 for Cannabis Withdrawal Syndrome
PleoPharma, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to PP-01, the company’s lead investigational asset aimed at mitigating Cannabis ...
Hosted on MSN19hOpinion
Public Health Is Under Assault. Here's How Doctors Can Fight Back.
For doctors and for public and global health, the Trump administration's executive orders and plans are beyond worrisome, as ...
Americans' Big Health Care Concerns? Affordability and Access, Says Gallup
In the early, busy weeks of President Trump's administration, a new survey shows how Americans would define a healthy America ...